CA2877938C - Vaccin a adn, destine a etre utilise chez des patients atteints de cancer du pancreas - Google Patents

Vaccin a adn, destine a etre utilise chez des patients atteints de cancer du pancreas

Info

Publication number
CA2877938C
CA2877938C CA2877938A CA2877938A CA2877938C CA 2877938 C CA2877938 C CA 2877938C CA 2877938 A CA2877938 A CA 2877938A CA 2877938 A CA2877938 A CA 2877938A CA 2877938 C CA2877938 C CA 2877938C
Authority
CA
Canada
Prior art keywords
vaccine
dna
dna vaccine
vegfr
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2877938A
Other languages
English (en)
Other versions
CA2877938A1 (fr
Inventor
Heinz Lubenau
Original Assignee
Vaximm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaximm AG filed Critical Vaximm AG
Priority claimed from PCT/EP2013/001882 external-priority patent/WO2014005683A1/fr
Publication of CA2877938A1 publication Critical patent/CA2877938A1/fr
Application granted granted Critical
Publication of CA2877938C publication Critical patent/CA2877938C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne une souche mutante atténuée de Salmonella comprenant une molécule d'ADN recombinante codant pour une protéine de récepteur de VEGF. En particulier, la présente invention concerne l'utilisation de ladite souche mutante atténuée de Salmonella en immunothérapie contre le cancer.
CA2877938A 2012-07-05 2013-06-26 Vaccin a adn, destine a etre utilise chez des patients atteints de cancer du pancreas Active CA2877938C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12004995.2 2012-07-05
EP12004995 2012-07-05
PCT/EP2013/001882 WO2014005683A1 (fr) 2012-07-05 2013-06-26 Vaccin à adn, destiné à être utilisé chez des patients atteints de cancer du pancréas

Publications (2)

Publication Number Publication Date
CA2877938A1 CA2877938A1 (fr) 2014-01-09
CA2877938C true CA2877938C (fr) 2025-07-22

Family

ID=

Similar Documents

Publication Publication Date Title
US10293037B2 (en) DNA vaccine for use in pancreatic cancer patients
JP6662787B2 (ja) 癌免疫療法のための新規ｍｓｌｎ標的化ｄｎａワクチン
US20210077605A1 (en) Vegfr-2 targeting dna vaccine for combination therapy
JP2023160838A (ja) 新規ｖｅｇｆｒ－２ターゲット免疫療法アプローチ
JP2020511139A (ja) がん免疫療法のための新規ｐｄ−ｌ１標的ｄｎａワクチン
JP2019533698A (ja) 併用療法のためのｗｔ１標的指向性ｄｎａワクチン
US20230121528A1 (en) Salmonella-based dna vaccines in combination with an antibiotic